BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:bimagrumab readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of bimagrumab\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07920887-154@assetmemo.bio
DTSTAMP:20261121T004517Z
DTSTART;VALUE=DATE:20290731
DTEND;VALUE=DATE:20290801
SUMMARY:bimagrumab: Phase 2 readout est. (NCT07920887)
DESCRIPTION:bimagrumab\, phase 2.\nStudy: A Study of Bimagrumab in Particip
 ants With HFpEF\nEstimated primary completion: July 2029. This is a Clinic
 alTrials.gov estimate\, not a confirmed readout date\, and it can move.\nD
 rug page: https://assetmemo.bio/drug/bimagrumab#upcoming-events\nRegistry 
 record: https://clinicaltrials.gov/study/NCT07920887
URL:https://assetmemo.bio/drug/bimagrumab#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
